275 related articles for article (PubMed ID: 28659881)
21. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
22. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Yuan X; Lin Q; Tang G; Mao L; Song H; Wang F; Sun Z
Int J Clin Pract; 2021 Apr; 75(4):e13831. PubMed ID: 33175465
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
Front Immunol; 2019; 10():2948. PubMed ID: 31921195
[No Abstract] [Full Text] [Related]
25. Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
Herrera M; Keynan Y; McLaren PJ; Isaza JP; Abrenica B; López L; Marin D; Rueda ZV
PLoS One; 2022; 17(9):e0274257. PubMed ID: 36170228
[TBL] [Abstract][Full Text] [Related]
26. Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification.
Luo D; Yang BY; Qin K; Shi CY; Wei NS; Li H; Qin YX; Liu G; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Dong BQ; Li J
Infect Drug Resist; 2023; 16():6121-6138. PubMed ID: 37719654
[TBL] [Abstract][Full Text] [Related]
27. The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection.
Mirzaei R; Babakhani S; Ajorloo P; Ahmadi RH; Hosseini-Fard SR; Keyvani H; Ahmadyousefi Y; Teimoori A; Zamani F; Karampoor S; Yousefimashouf R
Mol Med; 2021 Apr; 27(1):34. PubMed ID: 33794771
[TBL] [Abstract][Full Text] [Related]
28. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis.
Huang Y; Tang JH; Cai Z; Qi Y; Jiang S; Ma TT; Yue Y; Huang F; Yang H; Ma YY
Tuberculosis (Edinb); 2022 Sep; 136():102231. PubMed ID: 35964506
[TBL] [Abstract][Full Text] [Related]
29. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
30. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
[TBL] [Abstract][Full Text] [Related]
31. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.
Delemarre EM; van Hoorn L; Bossink AWJ; Drylewicz J; Joosten SA; Ottenhoff THM; Akkerman OW; Goletti D; Petruccioli E; Navarra A; van den Broek BTA; Paardekooper SPA; van Haeften I; Koenderman L; Lammers JJ; Thijsen SFT; Hofland RW; Nierkens S
Front Immunol; 2021; 12():725447. PubMed ID: 34691031
[TBL] [Abstract][Full Text] [Related]
32. The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations.
Luo D; Shi CY; Wei NS; Yang BY; Qin K; Liu G; Dong BQ; Qin YX; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Li H; Li J
Tuberculosis (Edinb); 2023 Dec; 143():102413. PubMed ID: 37832478
[TBL] [Abstract][Full Text] [Related]
33. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
[TBL] [Abstract][Full Text] [Related]
34. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
Wayengera M; Kateete DP; Asiimwe B; Joloba ML
BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection.
Pan L; Wei N; Jia H; Gao M; Chen X; Wei R; Sun Q; Gu S; Du B; Xing A; Zhang Z
Oncotarget; 2017 Dec; 8(68):112907-112916. PubMed ID: 29348876
[TBL] [Abstract][Full Text] [Related]
36. Age-Stratified T Cell Responses in Children Infected with
Dreesman A; Corbière V; Dirix V; Smits K; Debulpaep S; De Schutter I; Libin M; Singh M; Malfroot A; Locht C; Mascart F
Front Immunol; 2017; 8():1059. PubMed ID: 28928738
[TBL] [Abstract][Full Text] [Related]
37. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.
Burel JG; Singhania A; Dubelko P; Muller J; Tanner R; Parizotto E; Dedicoat M; Fletcher TE; Dunbar J; Cunningham AF; Lindestam Arlehamn CS; Catanzaro DG; Catanzaro A; Rodwell T; McShane H; O'Shea MK; Peters B
Tuberculosis (Edinb); 2021 Dec; 131():102127. PubMed ID: 34555657
[TBL] [Abstract][Full Text] [Related]
38. Sero-diagnosis of Active
Wayengera M; Mwebaza I; Welishe J; Nakimuli C; Kateete DP; Wampande E; Kirimunda S; Bayigga L; Musubika C; Babirye P; Asiimwe B; Joloba ML
Mycobact Dis; 2017 Jun; 7(2):. PubMed ID: 28856068
[TBL] [Abstract][Full Text] [Related]
39. Novel Biomarker Panel of Let-7d-5p and MiR-140-5p Can Distinguish Latent Tuberculosis Infection from Active Tuberculosis Patients.
Liu J; Li Y; Liu T; Shi Y; Wang Y; Wu J; Qi Y
Infect Drug Resist; 2023; 16():3847-3859. PubMed ID: 37346367
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Potential of IgG and IgA Responses to
Lee JY; Kim BJ; Koo HK; Kim J; Kim JM; Kook YH; Kim BJ
Microorganisms; 2020 Jun; 8(7):. PubMed ID: 32629849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
